Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00000122Phase 3Completed
Phase 3, randomised trial of fluorouracil in Glaucoma (2 arms), sponsored by National Eye Institute. Primary endpoint: Success rate of filtering surgery at 5 years. Started Sep 1985; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00000122.